SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 27.96 |
| Enterprise Value ($M) | -4.40 |
| Book Value ($M) | 0.55 |
| Book Value / Share | 0.01 |
| Price / Book | 51.12 |
| NCAV ($M) | -0.21 |
| NCAV / Share | -0.00 |
| Price / NCAV | -135.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -56.20 |
| Return on Assets (ROA) | -0.69 |
| Return on Equity (ROE) | -1.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.35 |
| Current Ratio | 2.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.54 |
| Assets | 38.29 |
| Liabilities | 37.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 11.00 |
| Operating Income | -73.94 |
| Net Income | -69.78 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted Distributed | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -71.94 |
| Cash from Investing | 0.00 |
| Cash from Financing | 9.51 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Acorn Bioventures, L.p. | 8.30 | 19.92 | |
| 13G/A | Highbridge Capital Management Llc | 7.70 | -34.15 | |
| 13G | OPOKA INVESTMENT FUND Co | 6.10 | ||
| 13G/A | Short Jay M Phd | 6.60 | 11.78 | |
| 13G/A | Millennium Management Llc | 1.90 | -54.63 | |
| 13G/A | Tang Capital Management Llc | 1.80 | ||
| 13D/A | Soleus Private Equity Fund I, L.P. | 2.56 | -53.26 | |
| 13G/A | BlackRock, Inc. | 1.60 | -72.55 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 57,787 | 266,104 | 21.72 | |
| 111,247 | 498,982 | 22.29 | |
| 257,183 | 899,263 | 28.60 | |
| 441,169 | 916,859 | 48.12 | |
| 719,765 | 2,179,664 | 33.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVBP – ArriVent BioPharma, Inc. | AVDL – Avadel Pharmaceuticals plc |
| AXSM – Axsome Therapeutics, Inc. | BHST – BioHarvest Sciences Inc. |
| BTMD – biote Corp. |
Financial data and stock pages provided by
Fintel.io